탭메뉴
| 번호 | 구분 | 제목 |
|---|---|---|
| 293 | (국외)SCI | The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma |
| 292 | (국외)SCIE | Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade |
| 291 | (국외)SCIE | Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis |
| 290 | (국외)SCIE | Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab |
| 289 | (국외)SCIE | A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life of opioid-naive or opioid-resistant patients |
| 288 | (국외)SCIE | Atezolizumab/bevacizumab vs. lenvatinib as first-line therapy for unresectable hepatocellular carcinoma: a real-world, multi-center study. |
| 287 | (국외)SCIE | A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life of opioid-naive or opioid-resistant patients |
| 286 | (국외)SCIE | "Combination of Abemaciclib following Eribulin Overcomes Palbociclib-Resistant Breast Cancer by Inhibiting the G2/M Cell Cycle Phase" |
| 285 | (국외)SCIE | Efficacy and Safety of Atezolizumab plus Bevacizumab in Korean Patients with Advanced Hepatocellular Carcinoma |
| 284 | (국외)SCIE | Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway. |
Copyright ⓒ chamc, All rights reserved.
